Pain
News from the FDA/CDC
Opioid prescribing drops nationally, remains high in some counties
The CDC calls for “more consistency among health care providers” when it comes to prescribing opioids.
Latest News
New on the streets: Drug for nerve pain boosts high for opioid abusers
ATHENS, OHIO – On April 5, Ciera Smith sat in a car parked on the gravel driveway of the Rural Women’s Recovery Program here with a choice to make...
Feature
Follow five tips to mitigate opioid prescribing risks
Here’s how well-meaning doctors can avoid coming under government scrutiny for prescribing opioids and manage investigations and audits...
Feature
For opioid-related hospitalizations, men and women are equal
The gender gap increased in emergency department visits.
News from the FDA/CDC
FDA asks drug maker to shelve Opana ER
This marks the first time the agency has acted to remove an opioid pain medication because of the public health consequences of abuse.
From the Journals
Large-scale ERAS program reduces postoperative LOS, complications
Surgical quality improvement project takes implementation science to the next level.
From the Journals
Postop satisfaction scores not tied to restricted opioid prescribing
The concern that reducing opioid prescriptions may have a negative impact on patient satisfaction assessments may not be realized.
Conference Coverage
Postcesarean outpatient opioid needs predicted by inpatient use
SAN DIEGO – Tailoring prescriptions to predicted needs may help reduce the amount of unused opioids available for diversion.
Conference Coverage
Postop pain may be a predictor for readmission
PHILADELPHIA
From the Journals
Mortality rate was 10-fold higher in opioid use disorder patients
Individuals with opioid use disorder have a significantly higher mortality rate than the general population.
Conference Coverage
Liposomal bupivacaine cut need for opioids after gyn surgery
If you’re worried about opioid addiction, liposomal bupivacaine could be an option for pain control after outpatient gynecologic surgery.